pe26 schreef op 13 november 2015 14:24:
Techshares post:
"Crohn's very important in partnership discussion.
Believe filgotinib has excellent position for that disease. We feel very bullish about that".Hoe mooi wil je de one-liners hebben, had die vanochtend niet meegekund in publicatie.
Dit is pas een bijkoop moment.